Geode Capital Management LLC lifted its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 0.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 44,677,077 shares of the company's stock after acquiring an additional 399,846 shares during the period. Geode Capital Management LLC owned 2.33% of Kenvue worth $1,029,810,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in KVUE. M&T Bank Corp raised its holdings in Kenvue by 4.6% in the 3rd quarter. M&T Bank Corp now owns 106,594 shares of the company's stock worth $2,465,000 after acquiring an additional 4,654 shares during the last quarter. LRI Investments LLC boosted its position in shares of Kenvue by 49.1% during the third quarter. LRI Investments LLC now owns 19,232 shares of the company's stock valued at $454,000 after buying an additional 6,331 shares during the last quarter. Nomura Asset Management Co. Ltd. grew its stake in shares of Kenvue by 2.6% in the third quarter. Nomura Asset Management Co. Ltd. now owns 4,344,726 shares of the company's stock worth $100,494,000 after acquiring an additional 110,929 shares during the period. MML Investors Services LLC increased its position in Kenvue by 3.3% during the third quarter. MML Investors Services LLC now owns 179,130 shares of the company's stock valued at $4,143,000 after acquiring an additional 5,714 shares during the last quarter. Finally, XTX Topco Ltd lifted its stake in shares of Kenvue by 93.1% in the 3rd quarter. XTX Topco Ltd now owns 79,233 shares of the company's stock worth $1,833,000 after purchasing an additional 38,193 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on KVUE. Piper Sandler boosted their price objective on shares of Kenvue from $20.00 to $21.00 and gave the company a "neutral" rating in a research report on Monday, September 23rd. JPMorgan Chase & Co. raised their price objective on shares of Kenvue from $24.00 to $25.00 and gave the company an "overweight" rating in a research report on Friday, October 11th. Royal Bank of Canada upgraded Kenvue from a "hold" rating to a "moderate buy" rating in a research note on Monday. Deutsche Bank Aktiengesellschaft downgraded shares of Kenvue from a "buy" rating to a "hold" rating and lowered their target price for the stock from $25.00 to $24.00 in a report on Thursday. Finally, Jefferies Financial Group started coverage on shares of Kenvue in a report on Tuesday, September 24th. They issued a "buy" rating and a $27.00 price target on the stock. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $22.64.
Read Our Latest Report on KVUE
Kenvue Stock Up 0.5 %
Shares of KVUE stock traded up $0.10 on Thursday, hitting $22.32. The stock had a trading volume of 14,894,078 shares, compared to its average volume of 17,674,957. Kenvue Inc. has a one year low of $17.67 and a one year high of $24.46. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. The company has a market cap of $42.79 billion, a PE ratio of 40.58, a P/E/G ratio of 2.07 and a beta of 1.36. The business has a 50 day moving average price of $22.95 and a 200 day moving average price of $21.17.
Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.27 by $0.01. The business had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The company's quarterly revenue was down .4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.31 earnings per share. Research analysts anticipate that Kenvue Inc. will post 1.07 earnings per share for the current fiscal year.
Kenvue Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th were issued a $0.205 dividend. This represents a $0.82 annualized dividend and a yield of 3.67%. The ex-dividend date was Wednesday, November 13th. Kenvue's dividend payout ratio is presently 149.09%.
About Kenvue
(
Free Report)
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Featured Stories
Before you consider Kenvue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.
While Kenvue currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
